A European phase II study (BIOV-111) of clofarabine (Evoltra®) in refractory and relapsed childhood acute lymphoblastic leukemia:: Final results

被引：1

作者：

Kearns, Pamela ^{[1
,10
]}

Michel, Gerard ^{[2
,10
]}

Nelken, Brigitte ^{[3
,10
]}

Joel, Simon ^{[4
]}

Al-Ghazaly, Essam ^{[4
]}

Beishuizen, Auke ^{[5
,10
]}

Conter, Valentino ^{[6
,10
]}

Henze, Gunter ^{[7
,10
]}

Baruchel, Andre ^{[8
,10
]}

Saha, Vaskar ^{[9
]}

机构：

[1] Univ Birmingham, Inst Child Hlth, Birmingham B15 2TT, W Midlands, England

[2] Hosp Timone, Marseille, France

[3] Hosp Jeanne Flandre, Lille, France

[4] St Bartholomews Hosp, London, England

[5] Sophia Childrens Univ Hosp, Erasmus MC, Rotterdam, Netherlands

[6] Osped Nuovo San Gerardo, Monza, Italy

[7] Univ Med Berlin, Charite, Berlin, Germany

[8] Hop St Louis, Paris, France

[9] Univ Manchester, CRUK, Childrens Canc Grp, Manchester M13 9PL, Lancs, England

[10] IBFM Study Grp, Expt Therapeut Working Grp, Milan, Italy

来源：

关键词：

D O I：

10.1182/blood.V110.11.11.11

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：11A / 11A

页数：1